As previously described in IPD, sleep attacks in our LRRK2-PD patients were linked to the introduction of a dopamine agonist, obstructive sleep apnea or an increasedlevel of daytime sleepiness on the MSLT[3, 51]. Here, LRRK2 is linked to obstructive sleep apnea syndrome.